Find clinical trials for Multiple Sclerosis (MS) in New Haven, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Sclerosis (MS) trials near New Haven, CT, USA:
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...
Phase 3
Stony Brook, New York, United States and 107 other locations
(IV) (Part 1) and subcutaneous (SC) (Part 2) doses of RO7121932 and multiple ascending SC (Part 3) doses of RO7121932 in participants with m ...
Phase 1
New Haven, Connecticut, United States and 23 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Port Jefferson Station, New York, United States and 229 other locations
The primary objectives are to investigate the safety and tolerability of BIIB091 monotherapy in participants with relapsing multiple sclerosis...
Phase 2
Patchogue, New York, United States of America and 75 other locations
The purpose of this study is to evaluate the safety, tolerability, efficacy, and drug levels of CC-97540 in participants with Relapsing Forms of Multiple...
Phase 1
New Haven, Connecticut, United States and 34 other locations
for the overall conduct of the study at the site, confirmation of subject eligibility, routine study subject clinical management including for MS...
Phase 3
East Setauket, New York, United States and 60 other locations
as a single IV bolus to subjects with known gadolinium-enhancing central nervous system (CNS) lesions (for example stable brain tumor or multiple...
Phase 2
New Haven, Connecticut, United States and 3 other locations
This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sc...
Phase 3
New Haven, Connecticut, United States and 125 other locations
Phase 2/3, randomized, double-blind, placebo-controlled, single-treatment, multicenter trial assessing the efficacy and safety of MYOBLOC for the tre...
Phase 2, Phase 3
Stamford, Connecticut, United States of America and 8 other locations
It is an open label study to evaluate safety, tolerability and brain microglia response in participants with ALS following multiple doses of...
Phase 2
New Haven, Connecticut, United States and 9 other locations
Clinical trials
Research sites
Resources
Legal